Home » Prices » NASDAQ:CTIC

CTI BioPharma Corp. stock price

Today's NASDAQ:CTIC chart, history & news

Price:
3.71 USD
Change:
-0.03 (-0.8%)
Key Stats
Price open 3.78
Previous close 3.74
Market cap 273.62M
Volume 267.70K
Day high 3.82
Day low 3.66
Year high 3.82
Year low 0.6932
Year to date change 140.11%
P/E Ratio -5.44
Company Profile
Fundamentals
Insider Information
News

About CTI BioPharma Corp.

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Company information

Company name
CTI BioPharma Corp
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Other
Employees
25
CEO
Adam R. Craig
Address
3101 Western Avenue, Seattle, WA, 98121
Country
United States
Contact information
1.206.282.7100
Website
http://www.ctibiopharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.